Most Read
COVAX Announces new agreement, plans for first deliveries
January 22, 2021: COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for all countries, regardless of income...
FDA Approves OPDIVO® with CABOMETYX® as First-line Treatment for advanced Renal Cell Carcinoma
22 Jan 2021: Bristol Myers Squibb announced that OPDIVO®(nivolumab) 240 mg (injection for intravenous use) every two weeks or 480 mg every four weeks...
FDA granted approval of Cabenuva and Vocabria to ViiV Healthcare for HIV
January 21, 2021: "The U.S. FDA approved Cabenuva (cabotegravir and rilpivirine, injectable formulation) as a complete regimen for the treatment of human...
Pfizer, BioNTech’s COVID-19 vaccine Results are likely to be effective against UK strain
January 20, 2021: "Pfizer Inc. and BioNTechSE announced results f rom an in vitro study that provides additional data on the capability of sera...
